Alembic Pharmaceuticals Limited

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2023-04 to 2024-03🗂️ Report periods on file: 2023-04 to 2024-03

In its 2023-04 to 2024-03 reporting, Alembic Pharmaceuticals Limited disclosed greenhouse gas emissions of 909.8K tCO2e/year. By scope: Scope 1: 86.1K tCO2e/year; Scope 2: 67.5K tCO2e/year; Scope 3: 756.2K tCO2e/year. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
909.8K tCO2e/year
2023-04 to 2024-03
⚡
Renewable Energy
37%
of total energy
💧
Water Usage
612.8K KL/year
2023-04 to 2024-03
♻️
Waste
30.3K tons/year
2023-04 to 2024-03
⚙️
Energy Use
1.1M GJ/year
2023-04 to 2024-03

📊 Emissions by Scope (2023-04 to 2024-03)

ScopeWhat it coversReported value
Scope 1Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions).86.1K tCO2e/year
Scope 2Indirect emissions from purchased electricity, steam, heat and cooling.67.5K tCO2e/year
Scope 3Other indirect emissions across the value chain (purchased goods, business travel, use of sold products, etc.).756.2K tCO2e/year

New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.

✅ Reported Environmental Achievements

🎯 Climate & Sustainability Targets

🔜 Short-term

  • Increase renewable energy share from 37% to 50% in the next year
  • Reduce water consumption by 20%
  • Recycle 50% of water used
  • Reduce waste generation by 25%
  • Increase safety observations by 15%

📅 Medium-term

  • Achieve water neutrality by 2027
  • Reduce GHG emissions by 63% by 2035
  • Improve gender ratio from 4% to 10% by 2027
  • Increase beneficiaries from 1.48 lakhs to 2 lakhs by 2027
  • 30% vendor assessment against ESG criteria by 2027

🔭 Long-term

  • Achieve net zero emissions by 2050 aligned with 1.5 Degree C pathway

🌱 ESG Focus Areas

Water NeutralityClimate Change & GHG EmissionsEmployee Health and SafetyProduct Quality and SafetySustainable Supply ChainCommunity EngagementBusiness Ethics and Corporate GovernanceHuman Resource DevelopmentR&D and InnovationResilient Business Performance

⚠️ Challenges & Risks +

  • Scope 3 emissions accounting for 83.06% of total carbon footprint
  • Water scarcity
  • Maintaining gender ratio in a manufacturing company with remote locations

📋 Report Information

Reporting Period: 2023-04 to 2024-03
Frameworks: GRI Standards 2021, BRSR
Assurance: Bureau Veritas Industrial Services (India) Pvt. Ltd.